The Europe Viscosupplementation Market would witness market growth of 8.4% CAGR during the forecast period (2023-2030).
The currently available viscosupplements have exhibited clinical efficacy and are recognized as the most effective treatment option for knee osteoarthritis, stimulating market expansion. New products that deliver more effective effects are also being introduced to the market. For instance, during the International Cartilage Regeneration and Joint Preservation Society (ICRS) in June 2019, Anika Therapeutics, Inc. presented Hyalofast, a novel hyaluronic acid-based scaffold for cartilage regeneration.
The knee osteoarthritis sector will also grow due to increasing awareness-raising efforts by public and private organizations. The knee osteoarthritis industry will also grow due to individuals leading more sedentary lifestyles and an increase in the prevalence of knee osteoarthritis in the general population. Numerous factors, including trauma, obesity, and others, contribute to osteoarthritis. The OA affected body parts are afflicted with severe joint pain and stiffness. Osteoarthritis can be identified by symptoms like joint swelling, tingling in the limbs and legs, and decreased range of motion.
According to projections, the EU-27's total population would grow slightly from 446.8 million at the beginning of 2019 to a peak of 449.3 million between 2026 and 2029. By the year 2050, 129.8 million older persons, those who are 65 years of age or older, will live in the EU-27, up from 90.5 million at the beginning of 2019. In the EU-27, it is anticipated that the population between the ages of 75 and 84 will rise by 56.1% during this time, while that between the ages of 65 and 74 is expected to rise by 16.6%. Therefore, the high prevalence of obesity and aging population are expected to increase the growth of the market in the coming years.
The Germany market dominated the Europe Viscosupplementation Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $511 million by 2030. The UK market is exhibiting a CAGR of 7.5% during (2023 - 2030). Additionally, The France market would experience a CAGR of 9.2% during (2023 - 2030).
Based on Application, the market is segmented into Knee Osteoarthritis, Hand Osteoarthritis, Hip Osteoarthritis, and Others. Based on Product, the market is segmented into Three Injection, Single Injection, and Five Injection. Based on End-use, the market is segmented into Hospitals, and Orthopedic Clinics/ASCs. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Worldwide Viscosupplementation Market is Projected to reach USD 8.2 Billion by 2030, at a CAGR of 8.6%
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include DePuy Synthes (Johnson & Johnson), Sanofi S.A., Zimmer Biomet Holdings, Inc., Ferring Holdings SA, F. Hoffmann-La Roche Ltd., LG Chem Ltd. (LG Corporation), Anika Therapeutics, Inc., Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A), Smith & Nephew PLC and Seikagaku Corp.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Knee Osteoarthritis
- Hand Osteoarthritis
- Hip Osteoarthritis
- Others
By Product
- Three Injection
- Single Injection
- Five Injection
By End-use
- Hospitals
- Orthopedic Clinics/ASCs
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- DePuy Synthes (Johnson & Johnson)
- Sanofi S.A.
- Zimmer Biomet Holdings, Inc.
- Ferring Holdings SA
- F.Hoffmann-La Roche Ltd.
- LG Chem Ltd. (LG Corporation)
- Anika Therapeutics, Inc.
- Fidia Farmaceutici S.p.A. (P&R Farmaceutici S.p.A)
- Smith & Nephew PLC
- Seikagaku Corp.
TABLE 1 Europe Viscosupplementation Market, 2019 - 2022, USD Million
TABLE 2 Europe Viscosupplementation Market, 2023 - 2030, USD Million
TABLE 3 Europe Viscosupplementation Market by Application, 2019 - 2022, USD Million
TABLE 4 Europe Viscosupplementation Market by Application, 2023 - 2030, USD Million
TABLE 5 Europe Knee Osteoarthritis Market by Country, 2019 - 2022, USD Million
TABLE 6 Europe Knee Osteoarthritis Market by Country, 2023 - 2030, USD Million
TABLE 7 Europe Hand Osteoarthritis Market by Country, 2019 - 2022, USD Million
TABLE 8 Europe Hand Osteoarthritis Market by Country, 2023 - 2030, USD Million
TABLE 9 Europe Hip Osteoarthritis Market by Country, 2019 - 2022, USD Million
TABLE 10 Europe Hip Osteoarthritis Market by Country, 2023 - 2030, USD Million
TABLE 11 Europe Others Market by Country, 2019 - 2022, USD Million
TABLE 12 Europe Others Market by Country, 2023 - 2030, USD Million
TABLE 13 Europe Viscosupplementation Market by Product, 2019 - 2022, USD Million
TABLE 14 Europe Viscosupplementation Market by Product, 2023 - 2030, USD Million
TABLE 15 Europe Three Injection Market by Country, 2019 - 2022, USD Million
TABLE 16 Europe Three Injection Market by Country, 2023 - 2030, USD Million
TABLE 17 Europe Single Injection Market by Country, 2019 - 2022, USD Million
TABLE 18 Europe Single Injection Market by Country, 2023 - 2030, USD Million
TABLE 19 Europe Five Injection Market by Country, 2019 - 2022, USD Million
TABLE 20 Europe Five Injection Market by Country, 2023 - 2030, USD Million
TABLE 21 Europe Viscosupplementation Market by End-use, 2019 - 2022, USD Million
TABLE 22 Europe Viscosupplementation Market by End-use, 2023 - 2030, USD Million
TABLE 23 Europe Hospitals Market by Country, 2019 - 2022, USD Million
TABLE 24 Europe Hospitals Market by Country, 2023 - 2030, USD Million
TABLE 25 Europe Orthopedic Clinics/ASCs Market by Country, 2019 - 2022, USD Million
TABLE 26 Europe Orthopedic Clinics/ASCs Market by Country, 2023 - 2030, USD Million
TABLE 27 Europe Viscosupplementation Market by Country, 2019 - 2022, USD Million
TABLE 28 Europe Viscosupplementation Market by Country, 2023 - 2030, USD Million
TABLE 29 Germany Viscosupplementation Market, 2019 - 2022, USD Million
TABLE 30 Germany Viscosupplementation Market, 2023 - 2030, USD Million
TABLE 31 Germany Viscosupplementation Market by Application, 2019 - 2022, USD Million
TABLE 32 Germany Viscosupplementation Market by Application, 2023 - 2030, USD Million
TABLE 33 Germany Viscosupplementation Market by Product, 2019 - 2022, USD Million
TABLE 34 Germany Viscosupplementation Market by Product, 2023 - 2030, USD Million
TABLE 35 Germany Viscosupplementation Market by End-use, 2019 - 2022, USD Million
TABLE 36 Germany Viscosupplementation Market by End-use, 2023 - 2030, USD Million
TABLE 37 UK Viscosupplementation Market, 2019 - 2022, USD Million
TABLE 38 UK Viscosupplementation Market, 2023 - 2030, USD Million
TABLE 39 UK Viscosupplementation Market by Application, 2019 - 2022, USD Million
TABLE 40 UK Viscosupplementation Market by Application, 2023 - 2030, USD Million
TABLE 41 UK Viscosupplementation Market by Product, 2019 - 2022, USD Million
TABLE 42 UK Viscosupplementation Market by Product, 2023 - 2030, USD Million
TABLE 43 UK Viscosupplementation Market by End-use, 2019 - 2022, USD Million
TABLE 44 UK Viscosupplementation Market by End-use, 2023 - 2030, USD Million
TABLE 45 France Viscosupplementation Market, 2019 - 2022, USD Million
TABLE 46 France Viscosupplementation Market, 2023 - 2030, USD Million
TABLE 47 France Viscosupplementation Market by Application, 2019 - 2022, USD Million
TABLE 48 France Viscosupplementation Market by Application, 2023 - 2030, USD Million
TABLE 49 France Viscosupplementation Market by Product, 2019 - 2022, USD Million
TABLE 50 France Viscosupplementation Market by Product, 2023 - 2030, USD Million
TABLE 51 France Viscosupplementation Market by End-use, 2019 - 2022, USD Million
TABLE 52 France Viscosupplementation Market by End-use, 2023 - 2030, USD Million
TABLE 53 Russia Viscosupplementation Market, 2019 - 2022, USD Million
TABLE 54 Russia Viscosupplementation Market, 2023 - 2030, USD Million
TABLE 55 Russia Viscosupplementation Market by Application, 2019 - 2022, USD Million
TABLE 56 Russia Viscosupplementation Market by Application, 2023 - 2030, USD Million
TABLE 57 Russia Viscosupplementation Market by Product, 2019 - 2022, USD Million
TABLE 58 Russia Viscosupplementation Market by Product, 2023 - 2030, USD Million
TABLE 59 Russia Viscosupplementation Market by End-use, 2019 - 2022, USD Million
TABLE 60 Russia Viscosupplementation Market by End-use, 2023 - 2030, USD Million
TABLE 61 Spain Viscosupplementation Market, 2019 - 2022, USD Million
TABLE 62 Spain Viscosupplementation Market, 2023 - 2030, USD Million
TABLE 63 Spain Viscosupplementation Market by Application, 2019 - 2022, USD Million
TABLE 64 Spain Viscosupplementation Market by Application, 2023 - 2030, USD Million
TABLE 65 Spain Viscosupplementation Market by Product, 2019 - 2022, USD Million
TABLE 66 Spain Viscosupplementation Market by Product, 2023 - 2030, USD Million
TABLE 67 Spain Viscosupplementation Market by End-use, 2019 - 2022, USD Million
TABLE 68 Spain Viscosupplementation Market by End-use, 2023 - 2030, USD Million
TABLE 69 Italy Viscosupplementation Market, 2019 - 2022, USD Million
TABLE 70 Italy Viscosupplementation Market, 2023 - 2030, USD Million
TABLE 71 Italy Viscosupplementation Market by Application, 2019 - 2022, USD Million
TABLE 72 Italy Viscosupplementation Market by Application, 2023 - 2030, USD Million
TABLE 73 Italy Viscosupplementation Market by Product, 2019 - 2022, USD Million
TABLE 74 Italy Viscosupplementation Market by Product, 2023 - 2030, USD Million
TABLE 75 Italy Viscosupplementation Market by End-use, 2019 - 2022, USD Million
TABLE 76 Italy Viscosupplementation Market by End-use, 2023 - 2030, USD Million
TABLE 77 Rest of Europe Viscosupplementation Market, 2019 - 2022, USD Million
TABLE 78 Rest of Europe Viscosupplementation Market, 2023 - 2030, USD Million
TABLE 79 Rest of Europe Viscosupplementation Market by Application, 2019 - 2022, USD Million
TABLE 80 Rest of Europe Viscosupplementation Market by Application, 2023 - 2030, USD Million
TABLE 81 Rest of Europe Viscosupplementation Market by Product, 2019 - 2022, USD Million
TABLE 82 Rest of Europe Viscosupplementation Market by Product, 2023 - 2030, USD Million
TABLE 83 Rest of Europe Viscosupplementation Market by End-use, 2019 - 2022, USD Million
TABLE 84 Rest of Europe Viscosupplementation Market by End-use, 2023 - 2030, USD Million
TABLE 85 Key Information – DePuy Synthes
TABLE 86 Key Information – Sanofi S.A.
TABLE 87 key Information – Zimmer Biomet Holdings, Inc.
TABLE 88 key information – Ferring Holdings SA
TABLE 89 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 90 key information – LG Chem Ltd.
TABLE 91 Key Information – Anika Therapeutics, Inc.
TABLE 92 Key Information – Fidia Farmaceutici S.p.A.
TABLE 93 key Information – Smith & Nephew PLC
TABLE 94 Key Information – Seikagaku Corp.
List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Viscosupplementation Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting the Viscosupplementation Market
FIG 4 Porter’s Five Force Analysis: Viscosupplementation Market
FIG 5 Europe Viscosupplementation Market share by Application, 2022
FIG 6 Europe Viscosupplementation Market share by Application, 2030
FIG 7 Europe Viscosupplementation Market by Application, 2019 - 2030, USD Million
FIG 8 Europe Viscosupplementation Market share by Product, 2022
FIG 9 Europe Viscosupplementation Market share by Product, 2030
FIG 10 Europe Viscosupplementation Market by Product, 2019 - 2030, USD Million
FIG 11 Europe Viscosupplementation Market share by End-use, 2022
FIG 12 Europe Viscosupplementation Market share by End-use, 2030
FIG 13 Europe Viscosupplementation Market by End-use, 2019 - 2030, USD Million
FIG 14 Europe Viscosupplementation Market share by Country, 2022
FIG 15 Europe Viscosupplementation Market share by Country, 2030
FIG 16 Europe Viscosupplementation Market by Country, 2019 - 2030, USD Million
FIG 17 Swot Analysis: DePuy Synthes
FIG 18 Swot Analysis: Sanofi S.A.
FIG 19 Swot Analysis: Zimmer Biomet Holdings, Inc.
FIG 20 Swot Analysis: Ferring Holdings SA
FIG 21 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 22 Swot Analysis: LG Chem Ltd.
FIG 23 Swot Analysis: ANIKA THERAPEUTICS, INC.
FIG 24 Swot Analysis: FIDIA FARMACEUTICI S.P.A.
FIG 25 SWOT Analysis: Smith & Nephew PLC
FIG 26 Swot Analysis: SEIKAGAKU CORP.